Delivery Order SPE2DB24D2216-SPE2DB25FGPLP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $9,491.76 to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5 mL syringes. The contract is a firm fixed price delivery order with an ultimate completion date of July 21, 2025, and represents a competitively awarded, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order is...
- The Defense Logistics Agency awarded a $2,694.75 delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine syringes (0.5ML) on July 24, 2025, with an ultimate completion date of July 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a $26,366 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5mL syringes. This non-set-aside contract is classified as a delivery order with an ultimate completion date of August 1, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was competitively selected to...
- The Defense Logistics Agency awarded a delivery order valued at $8,319.30 to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5 mL syringes. The contract employs firm fixed pricing with no set-aside designation and an ultimate completion date of July 31, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this competitively awarded delivery order, which is issued under the company's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $36,721.80 to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5mL syringes. This competitively awarded, firm fixed-price delivery order was executed on August 4, 2025, with an ultimate completion date of August 5, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen Drug Corp's existing...
- The Defense Logistics Agency awarded a delivery order valued at $2,929.02 to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5mL syringes. This is a firm fixed price, competitive award with no set-aside designation, with an ultimate completion date of July 28, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $9,491.76 delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine syringes (0.5ML) on July 30, 2025, with completion targeted for July 31, 2025. This firm fixed-price contract represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a $2,661.00 delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine syringes (0.5mL) on July 29, 2025, with a completion date of July 30, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,306.15 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5mL syringe format, with an ultimate completion date of August 6, 2025. This non-set-aside contract was awarded on August 5, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor,...
- The Defense Logistics Agency awarded a delivery order valued at $3,258.75 to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5 mL syringes. This competitive award, made on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a firm fixed price delivery order with no set-aside designation. The vaccine will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger...
- SPE2DB24D2216Indefinite Delivery Contract
- SPE2DB24D2216-SPE2DB25FGPLPDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,661.00 to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5mL syringes. This non-set-aside, competitively awarded contract with firm fixed pricing was executed on August 7, 2025, with an ultimate completion date of August 8, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026. This delivery order represents a routine pharmaceutical supply transaction supporting military healthcare needs through DLA's medical supply chain. AmerisourceBergen Drug Corp holds significant federal contracting experience as a critical vendor for military and veteran healthcare systems, maintaining an extensive portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains. The company's IDC vehicle enables flexible procurement of vaccines, medications, medical devices, and related supplies to support Defense Health Agency and other government healthcare system requirements on a global basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 8/7/25 |